DE69511379D1 - Immunogens gegen gonadotropin releasing hormone - Google Patents
Immunogens gegen gonadotropin releasing hormoneInfo
- Publication number
- DE69511379D1 DE69511379D1 DE69511379T DE69511379T DE69511379D1 DE 69511379 D1 DE69511379 D1 DE 69511379D1 DE 69511379 T DE69511379 T DE 69511379T DE 69511379 T DE69511379 T DE 69511379T DE 69511379 D1 DE69511379 D1 DE 69511379D1
- Authority
- DE
- Germany
- Prior art keywords
- gegen
- immunogens
- releasing hormone
- gonadotropin releasing
- immunogenic compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/852—Sperm
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/852—Sperm
- Y10S530/853—Ovary; eggs; embryos
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/854—Glands
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/11—Gonadotropin; related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/188,223 US5688506A (en) | 1994-01-27 | 1994-01-27 | Immunogens against gonadotropin releasing hormone |
PCT/US1995/001225 WO1995020600A1 (en) | 1994-01-27 | 1995-01-26 | Immunogens against gonadotropin releasing hormone |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69511379D1 true DE69511379D1 (en) | 1999-09-16 |
DE69511379T2 DE69511379T2 (de) | 1999-11-25 |
Family
ID=22692254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69511379T Expired - Fee Related DE69511379T2 (de) | 1994-01-27 | 1995-01-26 | Immunogens gegen gonadotropin releasing hormone |
Country Status (10)
Country | Link |
---|---|
US (3) | US5688506A (de) |
EP (1) | EP0741744B1 (de) |
JP (1) | JP3477713B2 (de) |
AT (1) | ATE183198T1 (de) |
AU (1) | AU698738B2 (de) |
DE (1) | DE69511379T2 (de) |
DK (1) | DK0741744T3 (de) |
ES (1) | ES2137498T3 (de) |
GR (1) | GR3031716T3 (de) |
WO (1) | WO1995020600A1 (de) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6030617A (en) * | 1993-01-12 | 2000-02-29 | The Johns Hopkins University School Of Medicine | Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
US5688506A (en) * | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
GB9514816D0 (en) | 1995-07-19 | 1995-09-20 | Ucli Ltd | Substances and their medical use |
ES2361474T3 (es) * | 1996-02-08 | 2011-06-17 | Cancer Advances, Inc. | Procedimientos inmunológicos para el tratamiento del cáncer gastrointestinal. |
CN1170593C (zh) * | 1997-05-12 | 2004-10-13 | 埃弗顿有限公司 | 缩胆囊素-b/胃泌素受体的免疫原性组合物以及治疗肿瘤的方法 |
US20040001842A1 (en) * | 1997-05-12 | 2004-01-01 | Dov Michaeli | Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors |
AUPO776897A0 (en) * | 1997-07-09 | 1997-07-31 | Csl Limited | A method of achieving production gains in livestock and agents useful for same |
US20030068326A1 (en) * | 1998-05-15 | 2003-04-10 | Aphton Corporation | Method for the treatment of gastroesophageal reflux disease |
JP2002515458A (ja) * | 1998-05-15 | 2002-05-28 | アフトン・コーポレーシヨン | 高ガストリン血症の予防および処置 |
AUPP807399A0 (en) | 1999-01-08 | 1999-02-04 | Csl Limited | Improved immunogenic lhrh composition and methods relating thereto |
GB9924351D0 (en) | 1999-10-14 | 1999-12-15 | Brennan Frank | Immunomodulation methods and compositions |
US20020058040A1 (en) * | 1999-12-23 | 2002-05-16 | Stephen Grimes | Stable immunogenic composition for frozen storage |
US6783761B2 (en) * | 2000-05-05 | 2004-08-31 | Aphton Corporation | Chimeric peptide immunogens |
ATE534401T1 (de) | 2000-10-18 | 2011-12-15 | Glaxosmithkline Biolog Sa | Mage antigen gekoppelt an einem protein d fragment enthaltende impfstoffe |
AU2002246758A1 (en) | 2000-12-29 | 2002-07-16 | Vanderbilt University | Epididymal lipocalin gene and uses thereof |
CA2441228A1 (en) * | 2001-03-23 | 2002-10-03 | Aphton Corporation | Combination treatment of pancreatic cancer |
US20090191232A1 (en) | 2001-05-04 | 2009-07-30 | Gevas Philip C | Combination therapy for the treatment of tumors |
US6810583B2 (en) * | 2001-08-07 | 2004-11-02 | International Business Machines Corporation | Coupling of conductive vias to complex power-signal substructures |
IL147138A0 (en) * | 2001-12-17 | 2002-08-14 | Yeda Res & Dev | Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation |
US20050169979A1 (en) * | 2002-07-03 | 2005-08-04 | Dov Michaeli | Liposomal vaccine |
US20040247661A1 (en) * | 2002-07-03 | 2004-12-09 | Dov Michaeli | Liposomal vaccine |
EP1528915A2 (de) * | 2002-07-03 | 2005-05-11 | Aphton Corporation | Liposomaler impfstoff |
CA2520010C (en) * | 2003-03-28 | 2012-07-10 | Aphton Corporation | Gastrin hormone immunoassays |
EP1684782B1 (de) | 2003-10-03 | 2015-09-30 | Thorn BioScience, LLC | Verfahren zur synchronisierung der ovulation für zeitlich angepasstes brüten ohne hitzenachweis |
CA2564562A1 (en) | 2004-04-26 | 2005-11-03 | Innate Pharma | Adjuvant composition and methods for its use |
WO2005120552A1 (en) * | 2004-06-11 | 2005-12-22 | Ym Biosciences Inc. | METHODS AND FORMULATIONS OF GnRH/LEUKOTOXIN CHIMERAS FOR TESTOSTERONE SUPPRESSION |
CA2580965C (en) | 2004-09-22 | 2014-04-08 | Receptor Biologix, Inc. | Monoclonal antibodies to progastrin |
TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
EP2010569A4 (de) | 2006-03-20 | 2009-09-09 | Xoma Technology Ltd | Für gastrin spezifische humane antikörper, materialien und methoden |
JP5452223B2 (ja) * | 2006-07-24 | 2014-03-26 | テトラロジック ファーマシューティカルズ コーポレーション | Iap阻害剤 |
US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
TR201807756T4 (tr) | 2006-09-26 | 2018-06-21 | Infectious Disease Res Inst | Sentetik adjuvan içeren aşı bileşimi. |
SI2086582T1 (sl) | 2006-10-12 | 2013-02-28 | Glaxosmithkline Biologicals S.A. | Cepivo, ki obsega emulzijo olja v vodi kot adjuvans |
EA015817B1 (ru) | 2006-10-12 | 2011-12-30 | Глаксосмитклайн Байолоджикалс С.А. | Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде" |
AR066676A1 (es) | 2007-05-24 | 2009-09-02 | Glaxosmithkline Biolog Sa | Composicion antigenica liofilizada que contiene un agonista del receptor tipo toll |
EP2072060A1 (de) | 2007-12-18 | 2009-06-24 | Institut Curie | Verfahren und Zusammensetzungen zur Herstellung und Verwendung von Toxinkonjugaten |
CA2739318A1 (en) * | 2008-08-07 | 2010-02-11 | Mercia Pharma, Llc | Immunotherapeutic compositions for the treatment of alzheimer's disease |
CU23739A1 (es) | 2008-09-30 | 2011-12-28 | Ct Ingenieria Genetica Biotech | Composición farmacéutica utilizando combinaciones de variantes de la hormona liberadora de las gonadotropinas (gnrh) como inmunógeno |
US8905913B2 (en) | 2009-04-23 | 2014-12-09 | Jbs United Animal Health Ii Llc | Method and composition for synchronizing time of insemination |
MX2011012836A (es) | 2009-06-05 | 2012-04-20 | Infectious Disease Res Inst | Adyuvantes sinteticos de glucopiranosil-lipido. |
US8283372B2 (en) | 2009-07-02 | 2012-10-09 | Tetralogic Pharmaceuticals Corp. | 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic |
EP2675473A1 (de) | 2011-02-15 | 2013-12-25 | Immune Design Corp. | Verfahren zur verbesserung von immunogenspezifischen immunreaktionen durch vektorisierte impfstoffe |
MX350795B (es) | 2011-04-08 | 2017-09-19 | Inmune Design Corp | Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares. |
GB201121571D0 (en) | 2011-12-15 | 2012-01-25 | Astrimmune Ltd | Compounds and uses thereof |
ES2729967T3 (es) | 2012-02-07 | 2019-11-07 | Infectious Disease Res Inst | Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas |
ES2673556T3 (es) | 2012-05-16 | 2018-06-22 | Immune Design Corp. | Vacunas para el VHS-2 |
US9770011B2 (en) | 2012-09-29 | 2017-09-26 | The Trustees Of The University Of Pennsylvania | Veterinary composition and methods for non-surgical neutering and castration |
CN113398243A (zh) | 2012-11-28 | 2021-09-17 | 联合动物健康第二有限责任公司 | 用于同步小母猪的授精时间的方法 |
EP3711768A1 (de) | 2013-04-18 | 2020-09-23 | Immune Design Corp. | Gla-monotherapie zur verwendung in der krebsbehandlung |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
KR102411781B1 (ko) | 2013-12-31 | 2022-06-22 | 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) | 단일 바이알 백신 제형 |
EP3169352A1 (de) | 2014-07-15 | 2017-05-24 | Immune Design Corp. | Prime-boost-therapieschemata mit einem tlr4-agonist-adjuvans und einem lentivirusvektor |
EP3443123B1 (de) | 2016-04-11 | 2021-08-11 | Board of Regents, The University of Texas System | Verfahren und zusammensetzungen zum nachweis der affinität einzelner t-zellrezeptoren und sequenz |
JP7195148B2 (ja) | 2016-05-16 | 2022-12-23 | アクセス ツー アドバンスト ヘルス インスティチュート | Tlrアゴニストを含有する製剤及び使用方法 |
WO2017200957A1 (en) | 2016-05-16 | 2017-11-23 | Infectious Disease Research Institute | Pegylated liposomes and methods of use |
KR20220165789A (ko) | 2016-06-01 | 2022-12-15 | 액세스 투 어드밴스드 헬스 인스티튜트 | 사이징제를 함유하는 나노명반 입자 |
EP3624841A4 (de) | 2017-06-15 | 2021-01-27 | Cancer Advances, Inc., | Zusammensetzungen und verfahren zur induzierung humoraler und zellulärer immunitäten gegen tumore und krebs |
KR20200028395A (ko) | 2017-06-15 | 2020-03-16 | 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) | 나노구조 지질 담체 및 안정적인 에멀션 그리고 이들의 용도 |
KR20200066309A (ko) | 2017-09-08 | 2020-06-09 | 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) | 사포닌을 포함하는 리포솜 제형 및 사용 방법 |
KR20220125149A (ko) | 2019-05-25 | 2022-09-14 | 액세스 투 어드밴스드 헬스 인스티튜트 | 애주번트 백신 에멀션을 분무 건조시키기 위한 조성물 및 방법 |
AU2021337493A1 (en) | 2020-09-04 | 2023-05-18 | Access To Advanced Health Institute | Co-lyophilized rna and nanostructured lipid carrier |
WO2022051024A1 (en) | 2020-09-04 | 2022-03-10 | Infectious Disease Research Institute | Genetically-adjuvanted rna vaccines |
US20240050561A1 (en) | 2020-12-23 | 2024-02-15 | Access To Advanced Health Institute | Solanesol vaccine adjuvants and methods of preparing same |
WO2024052882A1 (en) | 2022-09-09 | 2024-03-14 | Access To Advanced Health Institute | Immunogenic vaccine composition incorporating a saponin |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4302386A (en) * | 1978-08-25 | 1981-11-24 | The Ohio State University | Antigenic modification of polypeptides |
US4201770A (en) * | 1973-05-07 | 1980-05-06 | The Ohio State University | Antigenic modification of polypeptides |
US4526716A (en) * | 1981-11-20 | 1985-07-02 | The Ohio State University | Antigenic modification of polypeptides |
US4691006A (en) * | 1983-03-04 | 1987-09-01 | Ohio State University | Antigenic modification of polypeptides |
US4384995A (en) * | 1980-01-16 | 1983-05-24 | The Ohio State University | Antigenic modification of polypeptides |
US3963691A (en) * | 1974-10-07 | 1976-06-15 | Merck & Co., Inc. | Synthetic antigens of luteinizing hormone releasing hormone |
US4618598A (en) * | 1982-04-12 | 1986-10-21 | Duke University | Method of regulating hormone function or release |
US4879112A (en) * | 1984-02-07 | 1989-11-07 | University Of Saskatchewan | Monoclonal antibodies agaisnt GnRH |
US4676981A (en) * | 1984-02-07 | 1987-06-30 | University Of Saskatchewan | Monoclonal antibodies against GnRH |
US4608251A (en) * | 1984-11-09 | 1986-08-26 | Pitman-Moore, Inc. | LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues |
AU5359186A (en) * | 1985-01-25 | 1986-08-13 | Population Council, Inc., The | Method & product for enhancing circulating antibody response |
US4740500A (en) * | 1985-01-31 | 1988-04-26 | The Salk Institute For Biological Studies | GnRH antagonists VIII |
IL78775A (en) * | 1985-05-15 | 1992-06-21 | Biotech Australia Pty Ltd | Oral vaccines |
AU5993186A (en) * | 1985-06-04 | 1987-01-07 | Biotechnology Research Partners Limited | Autoantigen vaccines |
CA1239346A (en) * | 1985-06-04 | 1988-07-19 | Gursaran P. Talwar | Birth control vaccine |
FR2593705B1 (fr) | 1986-02-04 | 1991-07-26 | Lafon Labor | Composition pour l'interruption de la grossesse comprenant des anticorps monoclonaux reconnaissant l'hormone chorionique gonadotrope ou un peptide de structure analogue, anticorps monoclonaux, procede de production de ces anticorps, hybridomes et procede d'obtention de ces hybridomes |
US4795634A (en) * | 1986-03-14 | 1989-01-03 | Aphton Corporation | Method for contraception by immunization against the zona pellucida |
NZ220932A (en) * | 1986-07-03 | 1990-05-28 | Victoria State | Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying |
NZ221306A (en) * | 1986-08-15 | 1990-02-26 | Commw Scient Ind Res Org | 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof |
GB8713240D0 (en) * | 1987-06-05 | 1987-07-08 | Proteus Biotech Ltd | Hormones |
US4975420A (en) * | 1987-09-30 | 1990-12-04 | University Of Saskatchewan | Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals |
GB8723846D0 (en) * | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
FR2623715B1 (fr) | 1987-11-26 | 1990-12-21 | Lafon Labor | Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite |
JPH03502584A (ja) * | 1988-08-30 | 1991-06-13 | アプライド・リサーチ・システムス・エー・アール・エス・ホールディング・エヌ・ブイ | ホルモン分泌を変化させる組換え体融合タンパク質 |
US5036047A (en) * | 1988-09-29 | 1991-07-30 | Pitman-Moore, Inc. | Method and composition for preventing conception |
US5661126A (en) * | 1989-01-19 | 1997-08-26 | The General Hospital Corporation | Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression |
US5023077A (en) * | 1989-01-24 | 1991-06-11 | Aphton Corporation | Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
EP0380230B1 (de) * | 1989-01-24 | 1994-11-17 | Aphton Corporation | Immunogenische Zusammensetzungen gegen Gastrin-Peptide |
GB2228262B (en) * | 1989-01-25 | 1992-10-07 | Nat Inst Immunology | Antigenic derivative of gnrh |
WO1990009799A1 (en) | 1989-02-23 | 1990-09-07 | Colorado State University Research Foundation | GnRH ANALOGS FOR DESTROYING GONADOTROPHS |
US5484592A (en) * | 1989-03-23 | 1996-01-16 | Stitching Centraal Diergeneeskundig Instituut | Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs |
NZ235038A (en) * | 1989-08-25 | 1992-09-25 | Biotech Australia Pty Ltd | Outermembrane lipoprotein (tratp)/lhrh fusion protein and its use in immunological castration or reproductive inhibition |
GB8921470D0 (en) * | 1989-09-22 | 1989-11-08 | Peptide Technology Ltd | Vaccines |
DE4003944A1 (de) | 1990-02-14 | 1991-08-22 | Gerhard Dr Prinzhaus | Synthetisches polypeptid: lh - rh -- klh (konjugat aus luteinisierendem hormon-releasing hormon und dem keyhole limpet haemocyanin |
FR2661180B1 (fr) | 1990-04-23 | 1995-04-28 | Inst Nat Sante Rech Med | (hydroxyproline 9) lhrh, son procede d'obtention et application comme medicament. |
US5648340A (en) * | 1991-10-31 | 1997-07-15 | Barnea; Eytan R. | Gestational agents for controlling cell proliferation |
US5324512A (en) * | 1990-12-26 | 1994-06-28 | The Population Council | [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses |
GB9100468D0 (en) * | 1991-01-09 | 1991-02-20 | Proteus Molecular Design | Improvements in and relating to hormones |
NL9100151A (nl) * | 1991-01-29 | 1992-08-17 | Instituut Voor Veeteeltkundig | Werkwijze voor het volledig c.q. nagenoeg volledig elimineren van de "beregeur" van vlees van opgefokte mannelijke varkens door tijdens het opfokken de mannelijke varkens te immuniseren tegen het gnrh-hormoon. |
KR100257214B1 (ko) * | 1991-03-01 | 2000-05-15 | 데스꼴롱그 티에리 | 거세되지 않은 수컷가축의 고기의 관능적 품질을 개선하기 위한 방법 |
AU634379B2 (en) * | 1991-04-29 | 1993-02-18 | Csl Limited | Recombinant immunocastration vaccine |
US5262521A (en) * | 1991-06-07 | 1993-11-16 | Sri International | Isolated atrial peptide-degrading enzyme and novel compounds useful as inhibitors thereof |
EP0592512A1 (de) * | 1991-07-01 | 1994-04-20 | University Technologies International Inc. (Uti) | Nicht-desensibilisierende analoge von gnrh und andere biologisch aktive liganden |
US5955080A (en) * | 1991-07-26 | 1999-09-21 | Commonwealth Scientific And Industrial Research Organisation | Self-adjuvanting peptide vaccine delivery system and production thereof |
US5723129A (en) | 1991-10-16 | 1998-03-03 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
US5422110A (en) | 1991-10-16 | 1995-06-06 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
US5837268A (en) | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
WO1993008290A1 (en) | 1991-10-16 | 1993-04-29 | University Of Saskatchewan | Enhanced immunogenicity using leukotoxin chimeras |
GB9207731D0 (en) * | 1992-04-07 | 1992-05-27 | Proteus Molecular Design | Improvements in or relating to vaccines |
ZA934199B (en) * | 1992-06-18 | 1994-01-10 | Akzo Nv | Carrier system against gnrh |
DK0647275T3 (da) * | 1992-06-23 | 2005-01-24 | Sinai School Medicine | Kloning og ekspression af receptoren for gonatotropin-frigörende hormon |
US5557033A (en) * | 1992-09-22 | 1996-09-17 | Regents Of The University Of Minnesota | Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide |
FR2700855B1 (fr) * | 1993-01-28 | 1995-03-03 | Commissariat Energie Atomique | Dosage immunométrique d'un antigène ou d'un haptène. |
US5759551A (en) | 1993-04-27 | 1998-06-02 | United Biomedical, Inc. | Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines |
DE69431114T2 (de) * | 1993-04-27 | 2003-03-13 | United Biomedical Inc | Immunogene lhrh peptidkonstrukion und synthetische, universale immunstimulatoren als impfstoffe |
US5413990A (en) * | 1993-08-06 | 1995-05-09 | Tap Pharmaceuticals Inc. | N-terminus modified analogs of LHRH |
US5468494A (en) * | 1993-11-12 | 1995-11-21 | Aphton Corp. | Immunogenic compositions against human gastrin 17 |
US5688506A (en) * | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
US5508383A (en) * | 1994-03-09 | 1996-04-16 | Tap Holdings Inc. | Cyclic peptide LHRH antagonists |
US5506207A (en) * | 1994-03-18 | 1996-04-09 | The Salk Institute For Biological Studies | GNRH antagonists XIII |
CA2163325A1 (en) * | 1994-11-21 | 1996-05-22 | Kaneyoshi Kato | Amine compounds, their production and use |
AU7718696A (en) * | 1995-10-27 | 1997-05-15 | Merck & Co., Inc. | Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
WO1997015316A1 (en) * | 1995-10-27 | 1997-05-01 | Merck & Co., Inc. | Conjugates of gonadotropin releasing hormone |
-
1994
- 1994-01-27 US US08/188,223 patent/US5688506A/en not_active Expired - Fee Related
-
1995
- 1995-01-26 AT AT95909395T patent/ATE183198T1/de not_active IP Right Cessation
- 1995-01-26 DK DK95909395T patent/DK0741744T3/da active
- 1995-01-26 JP JP52023395A patent/JP3477713B2/ja not_active Expired - Fee Related
- 1995-01-26 WO PCT/US1995/001225 patent/WO1995020600A1/en active Search and Examination
- 1995-01-26 DE DE69511379T patent/DE69511379T2/de not_active Expired - Fee Related
- 1995-01-26 ES ES95909395T patent/ES2137498T3/es not_active Expired - Lifetime
- 1995-01-26 AU AU17371/95A patent/AU698738B2/en not_active Ceased
- 1995-01-26 EP EP95909395A patent/EP0741744B1/de not_active Expired - Lifetime
- 1995-06-07 US US08/478,546 patent/US6303123B1/en not_active Expired - Fee Related
-
1997
- 1997-11-17 US US08/968,466 patent/US6132720A/en not_active Expired - Fee Related
-
1999
- 1999-11-03 GR GR990402808T patent/GR3031716T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH09508391A (ja) | 1997-08-26 |
JP3477713B2 (ja) | 2003-12-10 |
EP0741744A1 (de) | 1996-11-13 |
AU698738B2 (en) | 1998-11-05 |
US6132720A (en) | 2000-10-17 |
AU1737195A (en) | 1995-08-15 |
EP0741744B1 (de) | 1999-08-11 |
US6303123B1 (en) | 2001-10-16 |
ATE183198T1 (de) | 1999-08-15 |
ES2137498T3 (es) | 1999-12-16 |
GR3031716T3 (en) | 2000-02-29 |
WO1995020600A1 (en) | 1995-08-03 |
DE69511379T2 (de) | 1999-11-25 |
DK0741744T3 (da) | 1999-12-06 |
US5688506A (en) | 1997-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69511379D1 (en) | Immunogens gegen gonadotropin releasing hormone | |
CA2161445A1 (en) | Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines | |
AU7980794A (en) | Methods and compositions for microencapsulation of antigens for use as vaccines | |
IL124459A0 (en) | Antagonists of gonadotropin releasing hormone | |
MX9804850A (es) | Antagonistas de hormona liberadora de gonadotropina. | |
MX9700534A (es) | Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para tratar las enfermedades de prostata, endometriosis y obesidad. | |
MD1920F2 (ro) | Compoziţie şi metodă de profilaxie sau frânare a debutului bolii Alzheimer | |
TJ242B (en) | A method of treatment an ovarian estrogen dependent condition | |
MX9101784A (es) | Formulaciones,metodos y dispositivos anticonceptivos transdermicos | |
PT771147E (pt) | Composições e métodos para imunidade celular tumoral in vivo melhorada | |
MX9804395A (es) | Proceso y equipo anticonceptivos para mamiferos hembra, que comprenden una combinacion de gestageno y estrogeno. | |
BG103170A (en) | Polymorphic form ii of finasteride and method for its preparation | |
CA2252604A1 (en) | Methods of treating type i hypersensitivity using monophosphoryl lipid a | |
MY116128A (en) | Vaccine composition | |
EP0282343A3 (de) | Verfahren zur Stimulierung der Immunreponsibilität zu bestimmten Antigenen | |
AU3991899A (en) | Verotoxin b subunit for immunization | |
MY128929A (en) | Vaccine against hepatitis a and hepatitis b | |
DE69711773T2 (de) | Ovulation auslösende arzneistoffe enthaltend luteinisierendes hormon | |
AU8934898A (en) | Use of droloxifene for the treatment of prostatic diseases endometriosis and obesity | |
IL132718A0 (en) | Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors | |
BG101173A (en) | Vaccine against pasteurellosis and haemorrhagic disease in rabbits | |
MX9705082A (es) | Composiciones para el suministro de antigenos. | |
BG51699A1 (en) | Stimulating fertility agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |